Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare the effectiveness of 3 drug schedules
in preventing chemotherapy-related nausea and/or vomiting in patients with acute myelogenous
leukemia (AML) or high-risk myelodysplastic syndrome (MDS).